Thyrotropin receptor (TSHR) autoantibodies (TRAbs) are a hallmark of Gravesâ€™ disease (GD). The aim of this study was to evaluate the diagnostic accuracy of a new third generation automatic fluorescence enzyme immunoassay for TRAb measurement in GD, in comparison with two current IMAs.